CBIO · Crescent Biopharma, Inc.
Market Cap
$775.57M
Shares
37.14M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1253689
CUSIP
G2545C104
13F (30d)
68 filings
68 filers
Visit website
Investor relations